Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12615000897561
Ethics application status
Approved
Date submitted
2/08/2015
Date registered
27/08/2015
Date last updated
25/06/2021
Date data sharing statement initially provided
16/11/2018
Date results provided
14/05/2019
Type of registration
Prospectively registered

Titles & IDs
Public title
Avoidance of endotracheal suction in routine, post operative cardiac patients.
Scientific title
Avoidance of endotracheal suction in routine, post-operative cardiac patients. A single centre, non-inferiority, randomised controlled trial assessing the safety and efficacy of avoiding endotracheal suction on patients having planned cardiac surgery who are ventilated for less than 12 hours.
Secondary ID [1] 287195 0
None
Universal Trial Number (UTN)
U1111-1172-83
Trial acronym
Nil
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Endotracheal Suction 295775 0
Post Operative Cardiac Surgery 295778 0
Artificial Ventilation 295779 0
Condition category
Condition code
Surgery 296052 296052 0 0
Other surgery

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
The avoidance of endotracheal (ETT) suction in patients undergoing planned cardiac surgery,who are ventilated for less than 12 hours. ETT suction is normally performed "as required". It is at the discretion of the bedside nurse and can vary from 2 hours to 4 hours. The aim of ETT suction is to maintain pulmonary hygiene, clear any secretions that the patient cannot remove by coughing. It also aims to maintain integrity of the the ETT.
Those patients in the intervention group, i.e. no suction, will have all the usual care of the post operative cardiac patient, however with no ETT being performed. All the usual ICU monitoring will be in use and there are no plans for earlier extubation of this group. There are predefined criteria for the non-suction group to receive suction if required and for patient safety.
It is intended that a data safety committee will be established and review the first 20 patients to ensure protocol compliance and patient safety.
Intervention code [1] 292477 0
Treatment: Other
Intervention code [2] 292576 0
Treatment: Surgery
Intervention code [3] 292577 0
Treatment: Devices
Comparator / control treatment
ETT suction is performed on all ventilated patients. A suction catheter, attached to a negative pressure vacuum, is inserted into the ETT and any excess secretions are removed. This is performed "as required" and can vary from 2 to 4 hours. "As required" is usually influenced by the training and experience of the bedside nurse. Suction is also frequently performed at the point of extubation, the aim being to prevent aspiration during the procedure. The bedside nurse usually decides upon when suction is performed as well as doing the intervention.

Control group
Active

Outcomes
Primary outcome [1] 295718 0
PaO2/FiO2 ratio 6 hours after extubation. This is 6 hours after extubation, as long as the patient is extubated within 12 hours of return to ICU. The outcome will be measured from the results of arterial blood gases, these provide data about the PaO2 and FiO2 that the patient is receiving. The primary outcome is the difference between the two groups.
Timepoint [1] 295718 0
6 hours after extubation.
Secondary outcome [1] 316300 0
1. Complications at extubation; defined as laryngeal spasm, vomiting, aspiration, oxygen de-saturation (SaO2 <90%). This data is recorded on the ICU chart and in the patient record. The data will be collected by research nurses who are also ICU nurses and familiar with ICU practice and procedures. When required that outcome will be assessed by the treating intensivist.
Timepoint [1] 316300 0
This will be collected from the time of extubation, up to 6 hours after extubation.
Secondary outcome [2] 316301 0
2. Requirement for the escalation of oxygen therapy; this is defined as increasing dyspnoea, tachypnoea (respiratory rate>25 breaths per minute) in the first 6 hours after extubation. This outcome will be assessed by reviewing the ICU chart and patient record. Any desaturation and action taken will be documented on the ICU chart. The number of episodes will be collected.
Timepoint [2] 316301 0
This will be collected from the time of extubation, up to 6 hours after extubation.
Secondary outcome [3] 316302 0
3. Oxygen saturation <90%. This will be the number of episodes of oxygen saturation below 90% from the time of extubation to 6 hours later. The patients have continuous pulse oximetry measured and recorded on the ICU chart. The data will be collected from reviewing the ICU charts and patient records.
Timepoint [3] 316302 0
This will be collected from the time of extubation, up to 6 hours after extubation.
Secondary outcome [4] 316303 0
4. Tachycardia (>100 bpm), this is the number of episodes of tachycardia during the 6 hours following extubation. This will be assessed from the ICU chart. The patients have continuous ECG monitoring while in the ICU.
Timepoint [4] 316303 0
This will be collected from the time of extubation, up to 6 hours after extubation.
Secondary outcome [5] 316304 0
5. Increased mean arterial pressure (>85mmHg). This is part of the routine monitoring for patients in ICU and is recored on the ICU chart. The number of episodes of increased MAP in the 6 hours after extubation will be collected. The outcome will be assessed from reviewing the ICU chart.
Timepoint [5] 316304 0
This will be collected from the time of extubation, up to 6 hours after extubation.
Secondary outcome [6] 316305 0
6. Re-intubation rates. This will be assessed from a review if the ICU chart and the patient record. It will be documented on both records.
Timepoint [6] 316305 0
This will be collected from the time of extubation, up to 6 hours after extubation.

Eligibility
Key inclusion criteria
1. Equal to or greater than 16 years old,
2. Patients having cardiac surgery with cardiopulmonary bypass (CPB),
3. Extubation expected within 12 hours of admission to CVICU
Minimum age
16 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Documented difficult intubation
2. Expected ventilation >12 hours
3. Clinician preference for the patient to receive ETT suction.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Patients will be screened and seen preoperatively to gain consent for participation in the study. Patients will be randomised 1:1 to either ETT suction or no ETT suction. Randomisation will be performed once the patient is admitted to the ICU post operatively. Patients will not be randomised if on admission to the ICU it is thought likely that they will remain intubated for > 12 hours.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Allocation sequence will be generated using computer software. This will provide computerised sequence generations and allocation concealment will be achieved through the use of sequentially numbered, opaque, sealed envelopes. The envelopes will contain the unique patient identifier code and the allocated treatment group. Block randomisation will ensure even allocation across both groups and minimise predictability of the allocation sequence.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Non-inferiority study
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
The non-inferiority margin has been set at 10%, this has been assessed as clinically acceptable, The sample size calculations have been base upon data available from a similar patient cohort who were receiving supplemental oxygen. There is no available data for patients not receiving supplemental and we judged a 10% change clinically acceptable, that is a change in P/F ratio from 301 to 270. To ensure adequate power the sample size was increased to 100 participants in each arm of the study. This will allow for those who will not be randomised on return to the unit or who are ventilated for >12 hours. The non-inferiority margin has been set as 10%.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
11/01/2016
Actual
1/05/2017
Date of last participant enrolment
Anticipated
31/12/2018
Actual
8/02/2019
Date of last data collection
Anticipated
31/12/2018
Actual
10/02/2019
Sample size
Target
200
Accrual to date
Final
250
Recruitment outside Australia
Country [1] 7064 0
New Zealand
State/province [1] 7064 0
Auckland

Funding & Sponsors
Funding source category [1] 291755 0
Charities/Societies/Foundations
Name [1] 291755 0
Auckland District Health Board Charitable A+ Trust
Country [1] 291755 0
New Zealand
Primary sponsor type
Individual
Name
Eileen Gilder
Address
CVICU Research
Auckland City Hospital
Level 4, Building 32,
2 Park Road
Auckland 1142
Country
New Zealand
Secondary sponsor category [1] 290427 0
None
Name [1] 290427 0
Address [1] 290427 0
Country [1] 290427 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 293278 0
Northern B Health and Disability Ethics Committee
Ethics committee address [1] 293278 0
Ethics committee country [1] 293278 0
New Zealand
Date submitted for ethics approval [1] 293278 0
24/07/2015
Approval date [1] 293278 0
08/10/2015
Ethics approval number [1] 293278 0
15/NTB/138

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes
Attachments [1] 644 644 0 0
/AnzctrAttachments/369045-HDEC_Letter_15NTB138_Approved_FULL_Application.pdf

Contacts
Principal investigator
Name 59238 0
Mrs Eileen Gilder.
Address 59238 0
CVICU, Ward 48,
Auckland City Hospital,
2 Park Road.
Grafton, 1142
Auckland
Country 59238 0
New Zealand
Phone 59238 0
+6493757100
Fax 59238 0
Email 59238 0
egilder@adhb.govt.nz
Contact person for public queries
Name 59239 0
Eileen Gilder
Address 59239 0
CVICU, Ward 48,
Auckland City Hospital,
2 Park Road.
Grafton, 1142
Auckland
Country 59239 0
New Zealand
Phone 59239 0
+6493757100
Fax 59239 0
Email 59239 0
egilder@adhb.govt.nz
Contact person for scientific queries
Name 59240 0
Eileen Gilder
Address 59240 0
CVICU, Ward 48,
Auckland City Hospital,
2 Park Road.
Grafton, 1142
Auckland
Country 59240 0
New Zealand
Phone 59240 0
+6493757100
Fax 59240 0
Email 59240 0
egilder@adhb.govt.nz

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
This has not been stated in the ethics application and would need review by ethics.


What supporting documents are/will be available?

Doc. No.TypeCitationLinkEmailOther DetailsAttachment
2080Statistical analysis plan    369045-(Uploaded-14-05-2019-09-11-41)-Study-related document.pdf



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
SourceTitleYear of PublicationDOI
EmbaseAvoidance of routine endotracheal suction in subjects ventilated for <= 12 hours following elective cardiac surgery.2020https://dx.doi.org/10.4187/respcare.07821
N.B. These documents automatically identified may not have been verified by the study sponsor.